Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI
Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI
复制标题
DOI:
10.2967/jnumed.118.209007
复制
发表时间:
2018-12-01
影响因子:
9.3
通讯作者:
Veit-Haibach, Patrick
中科院分区:
文献类型:
--
作者:
Sah, Bert-Ram;Ghafoor, Soleen;Veit-Haibach, Patrick
The goal of this study was to determine the level of clinically acceptable F-18-FDG dose reduction in time-of-flight PET/MRI in patients with breast cancer. Methods: Twenty-six consecutive women with histologically proven breast cancer were analyzed (median age, 51 y; range, 34-83 y). Simulated dose-reduced PET images were generated by unlisting the list-mode data on PET/MRI. The acquired 20-min PET frame was reconstructed in 5 ways: a reconstruction of the first 2 min with 3 iterations and 28 subsets for reference, and reconstructions simulating 100%, 20%, 10%, and 5% of the original dose. General image quality and artifacts, image sharpness, image noise, and lesion detectability were analyzed using a 4-point scale. Qualitative parameters were compared using the nonparametric Friedman test for multiple samples and the Wilcoxon signed-rank test for paired samples. Different groups of independent samples were compared using the Mann-Whitney U test. Results: Overall, 355 lesions (71 lesions with 5 different reconstructions each) were evaluated. The 20-min reconstruction with 100% injected dose showed the best results in all categories. For general image quality and artifacts, image sharpness, and noise, the reconstructions with a simulated dose of 20% and 10% were significantly better than the 2-min reconstructions (P